post-bg-502
calendary January 19, 2024

The Danish company Novo Nordisk will expand its portfolio of drugs for the treatment of obesity

According to Novo Nordisk's official website, the company is primarily engaged in the development and production of drugs for the treatment of type 1 and type 2 diabetes, obesity, dysplasia and hemophilia. In August, 2023 it became known that the Danish company plans purchase of the Canadian company Inversago Pharma for $1.07 billion.

Inversago Pharma is dedicated to developing treatments for people with obesity, diabetes and metabolic disorders. In particular, the company is working on the development of a drug based on the cannabinoid receptor blocker INV-202, which blocks appetite. Clinical studies of INV-202 have shown a favorable safety profile as well as efficacy in the fight against obesity.

It should be noted that Inversago Pharma's drug differs from Novo Nordisk's portfolio of drugs - Wegovy and Ozempik. The active ingredient in these drugs is semaglutide, a substance that mimics the GLP-1 hormone produced in the intestines, which signals the brain when a person is full.

Wegovy has shown impressive results in the Novo Nordisk trials. A five-year follow-up of patients showed that the incidence of heart attack, stroke, or death due to cardiovascular disease in patients taking Wegovy decreased by 20 %. The company plans to present the full results of the research by the end of this year.

However, there are concerns about this drug and its predecessor, Ozempic. The regulator in Iceland reported three patients who had suicidal or self-harming thoughts when taking the drug. As a result, a review of these drugs by the European Medicines Agency (EMA) was initiated.

According to data published by the EMA in July 2023, 150 reports of a possible relationship between the development of suicidal thoughts and the use of drugs based on semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda) were found.

The review is scheduled to be completed by November 2023.

References:
  1. https://www.novonordisk.ru/production.html
  2. https://vademec.ru/news/2023/08/11/novo-nordisk-za-1-mlrd-kupit-razrabotchika-preparatov-ot-ozhireniya-inversago/
  3. https://www.reuters.com/markets/deals/novo-nordisk-acquire-obesity-drug-developer-inversago-2023-08-10/
  4. https://gxpnews.net/2023/08/novo-nordisk-wegovy-snizil-risk-sosudistyh-katastrof-u-licz-s-ozhireniem-na-20/
  5. https://www.reuters.com/business/healthcare-pharmaceuticals/eu-probes-novos-weight-loss-drugs-reports-suicide-risks-bloomberg-news-2023-07-10/
  6. https://www.ema.europa.eu/en/news/ema-statement-ongoing-review-glp-1-receptor-agonists

More related posts

new-img-1

Control

Fine for spa resort in Yessentuki

Roszdravnadzor has imposed a fine of 130 thousand rubles on a spa resort in Yessentuki for improper storage of medical products…

03.03.2016
READ ARTICLE
new-img-2

Roszdravnadzor

Roszdravnadzor – patients’ rights

In 2015, Roszdravnadzor restored the rights of more than 460 thousand citizens to effective, accessible, and safe medical…

03.03.2016
READ ARTICLE
new-img-3

Regulation

The certification scheme for medical products hasn’t changed recently

Roszdravnadzor informs that the certification scheme for products in the Russian Federation is determined by Decree of the…

03.04.2016
READ ARTICLE
new-img-4

Control

Fines – Rostov region

In one and a half months of 2016, the Local Agency of Roszdravnadzor in Rostov Region imposed fines of the total amount of…

03.10.2016
READ ARTICLE
new-img-5

Control

Unregistered medical products

Two citizens were fined for selling unregistered medicinal products on the Internet in the Republic of Bashkortostan.

03.10.2016
READ ARTICLE
new-img-6

Control

Unscheduled inspection by roszdravnadzor

Roszdravnadzor started an unscheduled inspection of the Federal State-Funded Institution of Sverdlovsk Region Kirovgrad Central…

03.14.2016
READ ARTICLE
new-img-7

Medical Devices

International medical device regulators forum (IMDRF)

The delegation of the Federal Service for Surveillance in Healthcare headed by Mikhail Murashko, Head of Roszdravnadzor,…

03.17.2016
READ ARTICLE
new-img-8

Pharmaceuticals

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF”

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF” in which pills the metal wire was found.

05.18.2016
READ ARTICLE
new-img-9

Roszdravnadzor

Medical equipment stands idle in the Pskov region

Roszdravnadzor (RZN) statement: the expensive medical equipment for the total amount of 342 million rubles stands idle in…

05.19.2016
READ ARTICLE
new-img-10

Control

Hospital control Jewish autonomous region

Roszdravnadzor has audited the activity of the Regional Budgetary Public Health Facility “Central district hospital of Lenin”…

05.20.2016
READ ARTICLE